However, it is critical to first understand how factors can affect the interpretation of these biomarkers, through an effect on physiological processes (e.g. peripheral clearance, blood volume), or amyloid pathology and neuropathological burden directly (e.g. APOE ε4), being established risk factors for AD. This evidence concerns the gene APOE and amyloidosis.